NGeneBio Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was KRW 20.4 million compared to KRW 14.4 million a year ago. Net loss was KRW 9,785.44 million compared to KRW 8,431.08 million a year ago.

Basic loss per share from continuing operations was KRW 784 compared to KRW 682 a year ago. Diluted loss per share from continuing operations was KRW 784 compared to KRW 682 a year ago. Basic loss per share was KRW 784 compared to KRW 682 a year ago.